- Home
- MET vs HLN Comparison
MET vs HLN Comparison
Compare MET & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MET
- HLN
- Stock Information
- Founded
- MET 1863
- HLN 2022
- Country
- MET United States
- HLN United Kingdom
- Employees
- MET N/A
- HLN N/A
- Industry
- MET Life Insurance
- HLN Package Goods/Cosmetics
- Sector
- MET Finance
- HLN Consumer Discretionary
- Exchange
- MET Nasdaq
- HLN Nasdaq
- Market Cap
- MET 52.2B
- HLN 45.6B
- IPO Year
- MET N/A
- HLN N/A
- Fundamental
- Price
- MET $78.58
- HLN $11.35
- Analyst Decision
- MET Strong Buy
- HLN Buy
- Analyst Count
- MET 13
- HLN 1
- Target Price
- MET $93.08
- HLN $10.95
- AVG Volume (30 Days)
- MET 2.9M
- HLN 19.4M
- Earning Date
- MET 04-30-2025
- HLN 02-27-2025
- Dividend Yield
- MET 2.89%
- HLN 1.48%
- EPS Growth
- MET 112.38
- HLN 38.94
- EPS
- MET 6.14
- HLN 0.20
- Revenue
- MET $73,494,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- MET $5.51
- HLN $3.63
- Revenue Next Year
- MET $3.37
- HLN $4.37
- P/E Ratio
- MET $12.80
- HLN $27.81
- Revenue Growth
- MET 8.77
- HLN N/A
- 52 Week Low
- MET $65.21
- HLN $8.25
- 52 Week High
- MET $89.05
- HLN $11.40
- Technical
- Relative Strength Index (RSI)
- MET 51.78
- HLN 70.17
- Support Level
- MET $75.94
- HLN $11.01
- Resistance Level
- MET $79.38
- HLN $11.35
- Average True Range (ATR)
- MET 1.35
- HLN 0.13
- MACD
- MET -0.16
- HLN 0.04
- Stochastic Oscillator
- MET 44.59
- HLN 94.55
About MET MetLife Inc.
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.